Nootropics Market 2025 to 2034

Nootropics Market 2025 to 2034

Nootropics Market (By Form: Capsules/Tablets, Powder, Drinks; By Distribution Channel: Offline, Online; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.

Report ID: 11836 | Format: Databook | Published: January 2026 | Delivery: Immediate
Download Sample     Customisation Request  

Revenue, 2025

USD 21.33 Bn

Forecast Year, 2034

USD 73.11 Bn

CAGR, 2025 - 2034

14.74%

Report Coverage

Worldwide

Published By

Saurabh Bidwai

Reviewed By

Aditi Shivarkar

Reviewed By

Aman Singh

The global nootropics market, valued at USD 21.33 billion in 2025, is projected to surge to USD 73.11 billion by 2034, driven by rising cognitive health awareness, lifestyle adoption, and a robust 14.74% CAGR.

Nootropics Market Size Analysis

Nootropics Market Size By Form 2025 to 2034 (USD Billion)

Form 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Capsules/Tablets11.5013.2015.1417.3719.9322.8726.2430.1134.5539.64
Powder5.396.187.098.149.3410.7212.3014.1116.1918.58
Drinks4.445.105.856.717.708.8310.1311.6313.3415.31

Nootropics Market Size By Distribution Channel 2025 to 2034 (USD Billion)

Distribution Channel 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Offline12.0613.8415.8718.2120.9023.9827.5131.5736.2241.56
Online9.2710.6412.2114.0116.0718.4421.1624.2827.8531.96

Nootropics Market Size By Region 2025 to 2034 (USD Billion)

Region 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America7.548.659.9311.3913.0714.9917.2119.7422.6525.99
Europe5.746.597.568.679.9511.4213.1015.0317.2519.79
Asia Pacific5.185.956.827.838.9810.3111.8213.5715.5717.86
Latin America1.752.012.312.653.043.494.004.595.276.04
Middle East and Africa1.111.281.461.681.932.212.542.913.343.83

Nootropics Market Size to Hit USD 73.11 Billion by 2034

The global nootropics market size was calculated at USD 21.33 billion in 2025 and is predicted to attain around USD 73.11 billion by 2034 a CAGR of 14.74%.

Our Client